Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2912)
All Articles published online
|
Jan 14, 2005 (publication date) through Feb 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sheen IS, Jeng KS, Shih SC, Kao CR, Chang WH, Wang HY, Wang PC, Wang TE, Shyung LR, Chen CZ. Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11(2): 187-192 [PMID: 15633213 DOI: 10.3748/wjg.v11.i2.187] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i2/187.htm |
| Number | Citing Articles |
| 1 |
Decai Yu, Xitai Sun, Yudong Qiu, Jianxing Zhou, Yafu Wu, Lingyuan Zhuang, Jun Chen, Yitao Ding. Identification and Clinical Significance of Mobilized Endothelial Progenitor Cells in Tumor Vasculogenesis of Hepatocellular Carcinoma. Clinical Cancer Research 2007; 13(13): 3814 doi: 10.1158/1078-0432.CCR-06-2594
|
| 2 |
Jianquan Yang, Wen Guo, Man Lu. Recent Perspectives on the Mechanism of Recurrence After Ablation of Hepatocellular Carcinoma: A Mini-Review. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.895678
|
| 3 |
S J Schoenleber, D M Kurtz, J A Talwalkar, L R Roberts, G J Gores. Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis. British Journal of Cancer 2009; 100(9): 1385 doi: 10.1038/sj.bjc.6605017
|
| 4 |
Ahmed O. Kaseb, Amr Hanbali, Matthew Cotant, Manal M. Hassan, Ira Wollner, Philip A. Philip. Vascular endothelial growth factor in the management of hepatocellular carcinoma. Cancer 2009; 115(21): 4895 doi: 10.1002/cncr.24537
|
| 5 |
Zaher K. Otrock, Jawad A. Makarem, Ali I. Shamseddine. Vascular endothelial growth factor family of ligands and receptors: Review. Blood Cells, Molecules, and Diseases 2007; 38(3): 258 doi: 10.1016/j.bcmd.2006.12.003
|
| 6 |
Roberta Pang, Ronnie T.P. Poon. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Letters 2006; 242(2): 151 doi: 10.1016/j.canlet.2006.01.008
|
| 7 |
Johara Boldrini-França, Camila Takeno Cologna, Manuela Berto Pucca, Karla de Castro Figueiredo Bordon, Fernanda Gobbi Amorim, Fernando Antonio Pino Anjolette, Francielle Almeida Cordeiro, Gisele Adriano Wiezel, Felipe Augusto Cerni, Ernesto Lopes Pinheiro-Junior, Priscila Yumi Tanaka Shibao, Isabela Gobbo Ferreira, Isadora Sousa de Oliveira, Iara Aimê Cardoso, Eliane Candiani Arantes. Minor snake venom proteins: Structure, function and potential applications. Biochimica et Biophysica Acta (BBA) - General Subjects 2017; 1861(4): 824 doi: 10.1016/j.bbagen.2016.12.022
|
| 8 |
Mikhail S. Chesnokov, Polina A. Khesina, Darya A. Shavochkina, Inna F. Kustova, Leonid M. Dyakov, Olga V. Morozova, Nikolai S. Mugue, Nikolay E. Kudashkin, Ekaterina A. Moroz, Yuri I. Patyutko, Natalia L. Lazarevich. Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma. PeerJ 2018; 6: e4915 doi: 10.7717/peerj.4915
|
| 9 |
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular Carcinoma. The Anatomical Record 2008; 291(6): 721 doi: 10.1002/ar.20668
|
| 10 |
Mitsuro Kanda, Shuji Nomoto, Yoko Nishikawa, Hiroaki Sugimoto, Naohito Kanazumi, Shin Takeda, Akimasa Nakao. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico‐pathological parameters. Journal of Surgical Oncology 2008; 98(3): 190 doi: 10.1002/jso.21095
|
| 11 |
Jun Muto, Ken Shirabe, Keishi Sugimachi, Yoshihiko Maehara. Review of angiogenesis in hepatocellular carcinoma. Hepatology Research 2015; 45(1): 1 doi: 10.1111/hepr.12310
|
| 12 |
Cuiju Wang, Yalei Lv, Ziyue Sha, Jingjing Zhang, Jianhua Wu, Yixin Qi, Zhanjun Guo. Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway. Journal of Hepatocellular Carcinoma 2021; : 1643 doi: 10.2147/JHC.S327258
|
| 13 |
Shuxiao Li, Dandan Yang, Xin Ci, Xiaodan Lu, Yan Guo. Curative effect of the total saponins of Panax japonicus (TSPJ) on type 2 diabetes: Focusing on VEGFA. Gene 2024; 909: 148305 doi: 10.1016/j.gene.2024.148305
|
| 14 |
A. Donsante. Molecular and Cellular Therapies for Motor Neuron Diseases. 2017; : 167 doi: 10.1016/B978-0-12-802257-3.00008-0
|
| 15 |
Melanie B. Thomas, Jeffrey S. Morris, Romil Chadha, Michiko Iwasaki, Harmeet Kaur, Elinor Lin, Ahmed Kaseb, Katrina Glover, Marta Davila, James Abbruzzese. Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma. Journal of Clinical Oncology 2009; 27(6): 843 doi: 10.1200/JCO.2008.18.3301
|
| 16 |
Ming‐Yen Hsieh, Zu‐Yau Lin, Wan‐Long Chuang. Serial serum VEGF‐A, angiopoietin‐2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization. The Kaohsiung Journal of Medical Sciences 2011; 27(8): 314 doi: 10.1016/j.kjms.2011.03.008
|
| 17 |
Jian Kong, Jinge Kong, Bing Pan, Shan Ke, Shuying Dong, Xiuli Li, Aimin Zhou, Lemin Zheng, Wen-bing Sun, Mercedes Susan Mandell. Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA. PLoS ONE 2012; 7(5): e37266 doi: 10.1371/journal.pone.0037266
|
| 18 |
Loraine Kay D. Cabral, Claudio Tiribelli, Caecilia H. C. Sukowati. Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity. Cancers 2020; 12(6): 1576 doi: 10.3390/cancers12061576
|
| 19 |
Noha A. Sadik, Nagwa R. Ahmed, Moataz F. Mohamed, Omar A. Ashoush. Serum Vascular Endothelial Growth Factor in Patients with Hepatocellular Carcinoma and its Validity as a Tumor Biomarker. The Open Biomarkers Journal 2019; 9(1): 84 doi: 10.2174/1875318301909010084
|